908 Devices to Report Third Quarter 2026 Financial Results on November 10, 2026

908 Devices to Report Third Quarter 2026 Financial Results on November 10, 2026

BURLINGTON, Mass.–(BUSINESS WIRE)–
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the third quarter 2026 before market open on Tuesday, November 10, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.908devices.com. The webcast will be archived and available for replay within 24 hours after the event.

About 908 Devices

908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit www.908devices.com.

Matt Roache

VP, Investor Relations

[email protected]

www.908devices.com

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Technology Other Defense Medical Devices Security Chemicals/Plastics Software Manufacturing Hardware Health Defense

MEDIA:

Logo
Logo